NCT01160198View on ClinicalTrials.gov

A Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficiency Anaemia and to Compare These With Those of Ferrous Ascorbate.

PHASE3CompletedINTERVENTIONAL
Enrollment

271

Participants

Timeline

Start Date

October 13, 2010

Primary Completion Date

February 18, 2011

Study Completion Date

February 18, 2011

Conditions
Haematopoiesis
Interventions
DRUG

ferrous ascorbate

100 mg elemental iron

DIETARY_SUPPLEMENT

ferrous bisglycinate chelate 1 OD

60 mg elemental iron

DIETARY_SUPPLEMENT

ferrous bisglycinate chelate 2 OD

120 mg elemental iron

Trial Locations (7)

226003

GSK Investigational Site, Lucknow

226017

GSK Investigational Site, Lucknow

243202

GSK Investigational Site, Bhojipura, Bareilly

395002

GSK Investigational Site, Surat

400605

GSK Investigational Site, Thane,Mumbai

440022

GSK Investigational Site, Nagpur

411 001

GSK Investigational Site, Pune

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01160198 - A Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficiency Anaemia and to Compare These With Those of Ferrous Ascorbate. | Biotech Hunter | Biotech Hunter